Management of hepatitis C patients: a French population-based study

Cyril Hatem1, Anne Minello, Laurent Martin

  • 1EPI INSERM 0106, Centre d'Epidémiologie de Population, Faculté de Médecine, BP 87900, 21079 Dijon Cedex.

Insights

At least one in five hepatitis C patients in the general population do not receive specialized medical care. Management practices for hepatitis C infection vary significantly by gender.

Area of Science:

  • Hepatology
  • Public Health
  • Infectious Diseases

Background:

  • Hepatitis C infection requires timely access to specialized medical care for effective management.
  • Understanding patient pathways to care is crucial for improving public health outcomes.

Purpose of the Study:

  • To determine the proportion of hepatitis C patients accessing specialized medical care post-diagnosis.
  • To identify factors influencing access to care and treatment initiation.

Main Methods:

  • Analysis of a population-based registry of hepatitis C-positive patients in Cote-d'Or, France (1994-1999).
  • Inclusion of 690 eligible patients diagnosed with new hepatitis C serology.
  • Assessment of specialized care utilization, including liver biopsy and treatment.

Main Results:

  • 135 patients (19.6%) did not receive specialized medical care post-diagnosis.
  • Patients outside the healthcare system often had normal liver enzymes, lifestyle risk factors, or alcohol use.
  • Among those receiving care, 42.7% underwent liver biopsy and 27.0% were treated.
  • Treatment was more common in males and younger patients (<65 years).

Conclusions:

  • A significant proportion of hepatitis C patients remain outside the healthcare system.
  • Gender influences management practices and treatment initiation.
  • Further research is needed to elucidate barriers to care and optimize hepatitis C management strategies.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...